# Derivation of a health‐based guidance value for Δ8 ‐tetrahydrocannabinol (Δ8 ‐THC) and its occurrence in food

**Authors:** Helle Katrine Knutsen, Agneta Åkesson, Vasileios Bampidis, Margherita Bignami, James Kevin Chipman, Gisela Degen, Antonio Hernández‐Jerez, Tim Hofer, Christer Hogstrand, Stefano Landi, Jean‐Charles Leblanc, Kyriaki Machera, Evangelia Ntzani, Isabelle P. Oswald, Guido Rychen, Salomon Sand, Katharina Vejdovszky, Barbara Viviani, Birgit Dusemund, Carlo Nebbia, Stefan Weigel, Claudia Cascio, Anna Christodoulidou, José Cortiñas Abrahantes, Bruno Dujardin, Andrea Gissi, Lydia Alarcón Asensio, Eleni Gkimprixi, Tuuli Tauriainen, Laurent Bodin

PMC · DOI: 10.2903/j.efsa.2025.9735 · EFSA Journal · 2025-11-18

## TL;DR

This paper derives a health-based guidance value for Δ8-THC in food and assesses its occurrence alongside Δ9-THC in hemp products.

## Contribution

The study provides a relative potency factor and acute reference dose for Δ8-THC based on clinical data and occurrence analysis.

## Key findings

- The relative potency of Δ9-THC to Δ8-THC was estimated between 1 and 1.4.
- An acute reference dose of 1 μg/kg body weight was proposed for Δ8-THC.
- High detection rates of Δ8-THC were found in sweet and supplement products, suggesting possible enrichment or synthetic addition.

## Abstract

The European Food Safety Authority (EFSA) was asked to deliver a scientific opinion on the derivation of a health‐based guidance value (HBGV) for Δ8‐tetrahydrocannabinol (Δ8‐THC) in food with an assessment of the occurrence of Δ8‐THC and the co‐occurrence with Δ9‐THC in hemp and hemp‐derived products. Data from a clinical study were used to inform on the relative potency between Δ9‐THC and Δ8‐THC. The point estimate of the relative potency (ratio Δ9‐THC/Δ8‐THC) was in the range between 1 and 1.4, with 95% confidence between 0.97 and 1.63. Based on this range, the CONTAM Panel, using a conservative approach, set a relative potency factor of one for Δ8‐THC. The CONTAM Panel had previously set an acute reference dose (ARfD) of 1 μg/kg body weight for Δ9‐THC derived from adverse effects on human central nervous system (CNS). Given the similarity in the effects and the mode of action between Δ8‐THC and Δ9‐THC, the Panel considered that the established ARfD can be considered as a group ARfD for the sum of Δ8‐ and Δ9 THC. Regarding the occurrence of Δ8‐THC, the majority of samples were left censored, in particular for hemp infusion leaves, hemp seed oil and hemp seeds (96%–99%). Highest detection rates and levels were found in the categories ‘Sugar and similar, confectionery and water‐based sweet desserts’ and ‘Products for non‐standard diets, food imitates and food supplements’. Of 1145 samples, both substances were detected together in only 96 samples. If the two substances are produced naturally, a Δ8‐THC to Δ9‐THC ratio below 1 is expected; however, many of the samples, positive for Δ8‐THC, were above this ratio indicating either addition of semi‐synthetic Δ8‐THC, formation during processing or enrichment of the natural Δ8‐THC.

## Full-text entities

- **Chemicals:** oil (MESH:D009821), Delta8- (-), Delta9 THC (MESH:D013759), Delta8-THC (MESH:C035731)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12624367/full.md

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12624367/full.md

## References

186 references — full list in the complete paper: https://tomesphere.com/paper/PMC12624367/full.md

---
Source: https://tomesphere.com/paper/PMC12624367